Abstract: The present invention is based, at least in part, on novel, unimolecular STAT3 oligonucleotide decoys exhibiting increased in vivo stability as compared to previously known decoys which are effective in inhibiting STAT3 when administered systemically. The invention is also based on pharmaceutical compositions comprising these unimolecular decoys, and methods for using these decoys in the treatment of cancer.
Type:
Application
Filed:
June 7, 2012
Publication date:
November 15, 2012
Applicants:
Carnegie Melton, University of Pittsburgh - Of The Commonwealth System of Higher Education
Inventors:
Jennifer R. Grandis, Daniel Johnson, Danith Ly